OneOme Expands Team Ahead of Mid-year Launch of Comprehensive Pharmacogenomic Test

OneOme, LLC announced that it has hired Dr. Justin Odegaard, M.D., Ph.D. and Ross Higgins to manage and lead their pharmacogenomics testing laboratory.
According to the news:

Dr. Odegaard currently practices at Stanford University Hospital and is both lab and medical director at Guardant Health.  He was also previously the director of molecular pathology at LifeCode, a start-up company focused on the genetic basis of human disease. As the laboratory director, Dr. Odegaard will have sign-out responsibilities for the OneOme RightMed pharmacogenomics test. “I’m passionate about improving patient care and through pharmacogenomics, we can guide optimal drug selection for patients to maximize therapeutic effects, improve outcomes, and minimize toxicity,” stated Dr. Justin Odegaard..
Ross Higgins joins OneOme as the director of laboratory operations and will oversee all day to day activities within the lab. Previously, Ross served as the lab supervisor at Health Diagnostic Laboratory followed by several years with Douglas Scientific in business development and product management roles.

Click here to view the full press release.